ALL COMPANIES

CVN-424 is a small molecule dopamine signalling modulator aimed at improving motor impairment and managing "OFF" periods in Parkinson’s disease....

Tavapadon (PF-06649751) is a dopamine receptor agonist targeting motor impairment in Parkinson’s disease. This small molecule aims to improve motor...

ABBV-951 (LDP/LCD infusion)is a dopamine precursor delivered via continuous infusion, targeting motor impairment. This treatment provides levodopa/carbidopa in a more...

P2B-001 combines a dopamine agonist (pramipexole) and a MAO-B inhibitor (rasagiline) in a small molecule formulation. It targets motor impairment...

LY-03003 (rotigotine ER) is a dopamine receptor agonist formulated as an extended-release small molecule to treat motor impairment. By activating...

IPX-203 (LD/CD) is a dopamine precursor in small molecule form, designed to treat motor impairment by providing extended-release levodopa/carbidopa, helping...

ND-0612 (LD/CD pump) is a dopamine precursor delivered via a pump for continuous infusion, aimed at managing motor impairment by...

SPN-830 (apomorphine infusion) is a dopamine receptor agonist administered via infusion, intended to treat "OFF" periods in Parkinson’s disease by...

Alkahest (Part of Grifols) develops GRF-6021, a peptide derived from blood plasma fraction. It is being investigated for its ability...